Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Stock Traders Daily
Provider: New Constructs, LLC
Provider: Jefferson Research

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp Sees FY 2013 Revenue Guidance To Be Right At Or Slightly Ahead Of Prior Range-Conference Call

Friday, 17 May 2013 04:00pm EDT 

Celgene Corp announced that for fiscal 2013, it expects revenue to be right at or slightly ahead of $6 billion. According to I/B/E/S Estimates, analysts are expecting the Company to report revenue of $6.151 billion for fiscal 2013. 

Company Quote

3.75 +3.42%
26 Dec 2014